sildenafil-citrate and Diabetic-Foot

sildenafil-citrate has been researched along with Diabetic-Foot* in 1 studies

Other Studies

1 other study(ies) available for sildenafil-citrate and Diabetic-Foot

ArticleYear
A new approach at diabetic foot treatment: Phosphodiesterase 5 inhibitors.
    Medical hypotheses, 2020, Volume: 141

    Diabetic foot (DF), is one of the most serious and prevalent complications of diabetes mellitus (DM). Disruption in tissue oxygenation due to atherosclerosis in peripheral veins has an important place in DF development. In recent years, phosphodiesterase type 5 (PDE5) inhibitor drugs like sildenafil, which cause peripheral vasodilation, are used commonly in cases of erectile dysfunction, pulmonary hypertension and cardiac insufficiency. In that sense, PDE5 inhibitors, which cause vasodilation in peripheral veins, can increase blood build up in tissues of patients with DF and its stand-alone usage or its usage with already used treatments can increase tissue healing speed and quality.

    Topics: Diabetes Mellitus; Diabetic Foot; Erectile Dysfunction; Humans; Hypertension, Pulmonary; Male; Phosphodiesterase 5 Inhibitors; Sildenafil Citrate

2020